Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 30:27:100403.
doi: 10.1016/j.ensci.2022.100403. eCollection 2022 Jun.

Autoimmune glial fibrillary acidic protein astrocytopathy with delayed abnormal magnetic resonance imaging findings

Shohei Imanaka  1   2 , Yuwa Oka  1   3 , Akio Kimura  4 , Takayoshi Shimohata  4 , Sadayuki Matsumoto  1
Affiliations

Autoimmune glial fibrillary acidic protein astrocytopathy with delayed abnormal magnetic resonance imaging findings

Shohei Imanaka et al. eNeurologicalSci. .

Erratum in

No abstract available

Keywords: ADA, Adenosine Deaminase; Astrocytopathy; CSF, Cerebrospinal Fluid; GFAP, Glial Fibrillary Acidic Protein; Glial fibrillary acidic protein; MRI, Magnetic Resonance Imaging; Magnetic resonance imaging; Meningitis; anti-GFAPα, anti-Glial Fibrillary Acidic Protein antibody.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Brain MRI. Coronal view of gadolinium-enhanced FLAIR images and sagittal view of plain FLAIR images throughout treatment. On day 3, coronal images showing leptomeningeal enhancement over the sulcus of the left parietal lobe. Enhancement gradually improves. Axial FLAIR images from day 11 showing multiple linear high signals in the bilateral basal ganglia, cerebellum, and thalamus. Multiple linear high signals in the bilateral basal ganglia, thalamus, and cerebellum are resolved (days 18 and 39). MRI, magnetic resonance imaging; FLAIR, fluid-attenuated inversion recovery.
See this image and copyright information in PMC

References

    1. Fang B., McKeon A., Hinson S.R., Kryzer T.J., Pittock S.J., Aksamit A.J., et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol. 2016;73:1297–1307. - PubMed
    1. Kimura A., Takemura M., Yamamoto Y., Hayashi Y., Saito K., Shimohata T. Cytokines and biological markers in autoimmune GFAP astrocytopathy: the potential role for pathogenesis and therapeutic implications. J. Neuroimmunol. 2019;334 doi: 10.1016/j.jneuroim.2019.576999. - DOI - PubMed
    1. Kimura A., Takekoshi A., Yoshikura N., Hayashi Y., Shimohata T. Clinical characteristics of autoimmune GFAP astrocytopathy. J. Neuroimmunol. 2019;332:91–98. doi: 10.1016/j.jneuroim.2019.04.004. - DOI - PubMed
    1. Shan F., Long Y., Qiu W. Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front. Immunol. 2018;9:2802. - PMC - PubMed
    1. Yang X., Liang J., Huang Q., Xu H., Gao C., Long Y., et al. Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases. Neuroimmunomodulation. 2017;24:113–119. doi: 10.1159/000479948. - DOI - PubMed